HIF1A and breast cancer: Several previous studies[7–9] have shown that hypoxia inducible factor-1α (HIF-1α) was highly expressed in breast cancer, which was associated with increased risk of breast cancer recurrence and metastasis, chemoradiation resistance, immune escape, and poor prognosis.